The MoU was signed at a formal ceremony held at NSU campus. It was signed by NSU Vice-Chancellor Professor Abdul Hannan Chowdhury, and UniMed UniHealth Pharmaceuticals Chairman M Mosaddek Hossain, says a press release issued Sunday.
The ceremony was attended by Pro-VC (IC) of NSU, faculty members, researchers, and representatives from both institutions.
This strategic partnership aims to foster research and innovation, enhance the development of the pharmaceutical industry, and create opportunities for students and researchers to engage in practical, industry-driven projects, added the press release.
Speaking at the signing ceremony, Professor Abdul Hannan Chowdhury emphasised the significance of this partnership, stating, “This MoU marks a pivotal step in bridging academia and industry. By collaborating with UniMed UniHealth Pharmaceuticals Ltd., we aim to provide our students with hands-on learning experiences and contribute to cutting-edge research that will benefit Bangladesh’s healthcare sector.”
M Mosaddek Hossain also expressed enthusiasm about the collaboration, adding, “As one of the leading pharmaceutical companies in Bangladesh, we are committed to fostering innovation and research. This partnership with NSU will not only help in skill development but also create pathways for groundbreaking research in the pharmaceutical industry.”
Department of Pharmaceutical Sciences Chairman Professor Md Hossain Shariare said, “The collaboration will focus on pharmaceutical research, drug development, quality assurance, and regulatory affairs to contribute to the sustainable growth of the healthcare sector.”